INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 3 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,611,000 | +350.2% | 447 | +347.0% | 0.24% | +526.3% |
| Q3 2017 | $580,000 | -97.6% | 100 | -88.1% | 0.04% | -96.2% |
| Q1 2015 | $23,774,000 | +1726.0% | 843 | +1432.7% | 0.99% | +1880.0% |
| Q3 2014 | $1,302,000 | -19.1% | 55 | -19.1% | 0.05% | -27.5% |
| Q2 2014 | $1,609,000 | – | 68 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 95,000 | $1,761,300 | 0.01% |
| SIMPLEX TRADING, LLC | 55,300 | $1,025 | 0.00% |
| JANE STREET GROUP, LLC | 204,500 | $3,791,430 | 0.00% |
| JPMORGAN CHASE & CO | 56,000 | $1,038,240 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |